Skip to Main Content

Paper Details

Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Transplant Cell Ther
12
2021
Author NameAffiliation
Laura F NewellKnight Cancer Institute, Oregon Health & Science University
Rachel J CookKnight Cancer Institute, Oregon Health & Science University
Jessica LeonardKnight Cancer Institute, Oregon Health & Science University
Gabrielle MeyersKnight Cancer Institute, Oregon Health & Science University
Elie TraerKnight Cancer Institute, Oregon Health & Science University
Richard D PressKnight Cancer Institute, Oregon Health & Science University
Guang FanOregon Health & Science University
Richard T MaziarzKnight Cancer Institute, Oregon Health & Science University
Jennifer DunlapOregon Health & Science University
  • 1 - 9

Datasets

Release 1.2